Concepedia

Apar Pataer

AP

33

Publications

2.8K

Citations

24

H-Index

2006

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Beneficência Portuguesa de São Paulo

Thoracic Surgery Foundation

Sun Yat-sen University Cancer Center

Sun Yat-sen University

Apar Pataer is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, lung cancer, and oncology.

ORCID

Top concepts

Publications per year

2006–2025

33

Publications

33

Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial

Tina Cascone, William N. William, Annikka Weissferdt et al. · Nature Medicine · 2021 · 582 citations · Full text

, , +6

Histopathologic Response Criteria Predict Survival of Patients with Resected Lung Cancer After Neoadjuvant Chemotherapy

Apar Pataer, Neda Kalhor, Arlene M. Correa et al. · Journal of Thoracic Oncology · 2012 · 351 citations · Full text

, , +10

Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

Tina Cascone, Cheuk Hong Leung, Annikka Weissferdt et al. · Nature Medicine · 2023 · 191 citations · Full text

Effect of neoadjuvant chemotherapy on the immune microenvironment in non–small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches

Edwin R. Parra, Pamela Villalobos, Carmen Behrens et al. · Journal for ImmunoTherapy of Cancer · 2018 · 171 citations · Full text

Computed Tomography RECIST Assessment of Histopathologic Response and Prediction of Survival in Patients with Resectable Non–Small-Cell Lung Cancer after Neoadjuvant Chemotherapy

William N. William, Apar Pataer, Neda Kalhor et al. · Journal of Thoracic Oncology · 2013 · 133 citations · Full text

, , +14

Rows per page

1–5 of 33